SCHEMBL5383091

SCHEMBL5383091

CCCc1ccc(S(=O)(=O)Nc2ccc3onc(C)c3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
ATM Q13315 2/20 0.55
KIT P10721 2/20 0.53
FFAR4 Q5NUL3 2/20 0.50
BRD4 O60885 2/20 0.48
POLB P06746 1/20 0.47
EDNRA P25101 1/20 0.46
TP53 P04637 3/20 0.46
NR1I2 O75469 1/20 0.46
FFAR1 O14842 1/20 0.45
DRD2 P14416 3/20 0.45
DRD3 P35462 3/20 0.45
HTR6 P50406 3/20 0.45
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44
HIF1A Q16665 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN5 P54829 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5338915 0.78 MAPT (0.53) MAPTATMKITFFAR4POLB
SCHEMBL616006 0.77 PTPN2 (0.59) MAPTATMKITFFAR4NR1I2
SCHEMBL5335098 0.76 CDC7 (0.68) MAPTATMKITFFAR4POLB
SCHEMBL617843 0.74 MAPT (0.55) MAPTATMKITFFAR4POLB
SCHEMBL31681379 0.74 ATM (0.67) MAPTATMKITFFAR4POLB
SCHEMBL5389593 0.74 NR1I2 (0.58) MAPTATMKITFFAR4POLB
SCHEMBL5339207 0.74 ALDH1A1 (0.66) MAPTFFAR4CYP2C9
SCHEMBL617899 0.73 MAPT (0.59) MAPTATMKITFFAR4POLB
SCHEMBL25124383 0.72 GRM4 (0.47) MAPTBRD4POLBCYP1A2
SCHEMBL31681324 0.72 FFAR4 (0.63) MAPTATMKITFFAR4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 MAPT 4512/4885ATM 4236/4885KIT 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.